seed
Stage
1
Investors
About
Kylys Aesthetics develops medical devices for aesthetic applications based on a patented regenerative hyaluronic acid technology from the University of Geneva that promotes tissue regeneration for safer, more natural, and longer-lasting results.
Explore Kylys Aesthetics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.